SUPPLEMENTARY APPENDIX

Activity of secukinumab, an anti‒IL-17A antibody, on brain lesions in RRMS: Results from a randomized, proof-of-concept study

Journal of Neurology

Eva Havrdová,1 Anna Belova,2 Alla Goloborodko,3 Anne Tisserant,4 Andrew Wright,4 Erik Wallstroem,4 Hideki Garren,4 Ralph Paul Maguire,4 Donald R. Johns4 on behalf of the AIN457 for MS Study Group

1Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General Teaching Hospital, Charles University, Prague, Czech Republic; 2Institute for Traumatology and Orthopaedics of Minzdrav, Nizhny Novgorod, Russia; 3Department of Neurosurgery, Odessa Regional Clinical Hospital, Odessa, Ukraine; and 4Neuroscience Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland

Corresponding Author

Erik Wallstroem, MD, PhD

E-mail:

Supplementary Appendix Table. Participating study sites and Principal Investigators for Secukinumab Study B2201 (the AIN457 for MS Study Group)

Participating Site / Principal Investigator
Czech Republic
Fakultni nemocnice Královské Vinohrady
Neurologická Klinika
Praha 10 Praha 100 34 / David Doležil
Všeobecné Fakultní Nemocnice v Praze
Centrum pro Demyelinizační Onemocnění
Praha 2 Praha 128 08 / Eva Havrdová
Neurologická Odborná Ambulance
Ostrava-Moravská Ostrava a Přívoz 702 00 / Jiří Novák
Fakultní Nemocnice Hradec Králové
Neurologická Klinika
Hradec Králové 500 05 / Radomír Taláb
Nemocnice Teplice o.z.
Neurologické oddělení
Teplice 415 29 / Marta Váchová
Cerebrovaskulární Poradna s.r.o.
Ostrava 710 00 / Daniel Václavík
Russia
Municipal Clinical Hospital #3 (Nizhny Novgorod Geriatric Centre)
Nizhny Novgorod 603000 / Anna Belova
Republican Clinical Hospital for Rehabilitation of Public Health
Ministry of Republic of Tatarstan
Kazan Povolje-Tatarstan 120021 / Farit Khabirov
Smolensk State Medical Academy of RosZdrav
Centre of Clinical Studies of Diagnosis and Medical Agents
Department of Neurology
27, Gagarina Pr.
Smolensk 214018 / Natalia Maslova
Non-State Central Clinical Hospital #2 Named After N.A. Semashko of "OAO RGD"
43, Losinoostrovskaya Str.
Moscow 107150 / Olga Vorobyeva
Ukraine
Odessa Regional Clinical Hospital
Center of Neurology and Neurosurgery
Dept. of Neurosurgery
26, Acad Zabolotnogo Str.
Odessa 65117 / Alla Goloborodko
Kyiv City Clinical Hospital #9
Kyiv Center of Multiple Sclerosis
Kiev 03110 / Tetyana Kobys
Vinnitsa National Medical University
Dept. of Nervous Diseases
Vinnyts'ka oblast 21005 / Sergii Moskovko
State Treatment and Prophylactic Institution
Ukrzaliznytsi’s Central Hospital
Kharkiv 61018 / Igor Pasyura
City Clinical Hospital #9
Dept. of Neurology #1
Kiev 04112 / Tatyana Ryabichenko
Department of Neuroinfection
Institute of Neurology, Psychiatry and Narcology of the AMS of Ukraine
Kharkiv 61018 / Nataliya Voloshyná

1